Zhongshan, China · Founded 2021 · Privately Held (backing)
Developer of agonist antibody drugs intended for tumour targeting. Hengdong Shengwu is based in Zhongshan, China and was founded in 2021.
Last price · $/share
—
Implied valuation
—
Total raised
—
Last round
—
Cap table — not yet on record
Hengdong Shengwu's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Hengdong Shengwu with a free account
·Watch Hengdong Shengwu: the Monday email on marks, rounds and moves
